Med Life SA · BVB:M

Med Life SA — Q1 2019 Earnings Presentation

13 slides from Med Life SA's earnings presentation, 2019

  1. Slide 1: Conference Call Presentation for Q1 2019 Financial Results

    Conference Call Presentation for Q1 2019 Financial Results

  2. Slide 2: Legal Disclaimer

    LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. Neither this presentat

  3. Slide 3: Topics of Discussion

    TOPICS OF DISCUSSION I. MAIN EVENTS OF Q1 2019 4 II. KEY CHANGES Q1 2019 vs Q1 2018 5 III. MEDLIFE Q1 2019 FINANCIAL SNAPSHOT 8 IV. KEY OPERATIONAL METRICS FOR Q1 2019 11 V. Q&A SESSION 12

  4. Slide 4: Main Events of Q1 2019

    MAIN EVENTS OF Q1 2019 ACQUISITIONS • 51% of the shares in RMC Group, Hungary (finalized in March 2019) • Increase from 55% to 90% shares in Sama Group, Craiova • Increase from 80% to 83% shares in PDR Group, Brasov ORGANIC GROWTH • 2 Dent Estet clinics in Sibiu – one for adults, one for kids EXPANS

  5. Slide 5: Key Changes Q1 2019 vs Q1 2018

    KEY CHANGES Q1 2019 vs Q1 2018 Sales increased by : + 27.6% Pro-forma Q1 2019 vs. IFRS Q1 2018 SALES + 31.1% IFRS Q1 2019 vs. IFRS Q1 2018 + 15% like2like Improved margin: Before applying IFRS 16: 13.8% Pro-forma Q1 2019 vs. 12.2% IFRS Q1 2018 (fig_1 below) After applying IFRS 16: 17.8% Pro-forma Q1

  6. Slide 6: Key Changes Q1 2019 vs Q1 2018 (Cont.)

    KEY CHANGES Q1 2019 vs Q1 2018 (Cont.) Split of Pro-forma EBITDA between Owners of the Group / NCI for Q1 2019: 9.9% - 90.1% to Group Owners 90.1% - 9.9% to NCI EBITDA Vs. - 87.1% to Group Owners for IFRS Q1 2018 Pro-forma EBITDA to Group Owners - 12.9% to NCI for IFRS Q1 2018 Pro-forma EBITDA to NC

  7. Slide 7: Key Changes Q1 2019 vs Q1 2018 (Cont.)

    KEY CHANGES Q1 2019 vs Q1 2018 (Cont.) IFRS & Pro-forma: Decrease in Net Result was exclusively due to increased Financial Loss coming from: 1. Other financial expenses (i.e. loss from FX rate differences) in amount of 6.3m RON in Q1 2019 as compared to 300k RON in Q1 2018; and NET RESULT 2. IFRS 16

  8. Slide 8: MedLife Group Q1 2019 Financial Snapshot

    MEDLIFE GROUP Q1 2019 FINANCIAL SNAPSHOT Consolidated Statement of Financial Position IFRS 16 adjustments: 1. Right-of-use asset : 105,951,764 RON; 2. Deferred tax liability: 161,837 RON; 3. Lease liability (current and long term): 106,471,190 RON; and 4. Impact in net result: (681,263) RON. Page 8

  9. Slide 9: MedLife Group Q1 2019 Financial Snapshot (Cont.)

    MEDLIFE GROUP Q1 2019 FINANCIAL SNAPSHOT(Cont.) Consolidated Statement of Profit and Loss IFRS 16 adjustments: 1. Rent: release of 9,033,920 RON from Rent expense; 2. Depreciation: additional 8,541,867 RON in Depreciation expense; 3. EBITDA: increase of 9,003,920 RON; 4. Financial result: additional

  10. Slide 10: MedLife Group Q1 2019 Financial Snapshot (Cont.) - OPEX Evolution

    MEDLIFE GROUP Q1 2019 FINANCIAL SNAPSHOT(Cont.) OPEX Evolution Note: The Group recorded a 0.3 p.p. decrease of Operating Expenses as % of Sales in Q1 2019 as compared to Q1 2018, despite the increase in salaries that took place subsequent to March 2018: A. 5.2 p.p. decrease of “Rent” as % of Sales,

  11. Slide 11: Key Operational Metrics for Q1 2019

    KEY OPERATIONAL METICS FOR Q1 2019 Page 11

  12. Slide 12: Q&A Session

    © Med Life IV. Q&A SESSION PHSNe Page 12

  13. Slide 13: Thank You!

    THANK YOU! © MedLife

MedLife — Q1 2019 Earnings Presentation on 6ix